(ADPnews) - Oct 8, 2009 - Spanish biopharmaceutical company Grifols (MCE:GRF) has completed the placement of bonds worth USD 600 million (EUR 406.1m) in the USA, Grifols said yesterday.
The total demand exceeded USD 1 billion with 49 qualified investors taking part in the transaction. About 90% of the bonds were subscribed in dollars, the rest in …
Комментариев нет:
Отправить комментарий